Smaller product manufacturers are tapping Europe as a way to get their devices to market, a study by Northwestern University researchers has discovered. An investigation of more than 350 professionals found that two-thirds of the companies are seeking approvals in Europe first. This suggests, they said, a “delayed market entry” in the United States. The perceived unpredictability of the Food and Drug Administration’s approval process is the most commonly cited reason for the shift.
Why more products are looking like European imports
May 31, 2011